Verve Therapeutics(VERV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VERV Verve Therapeutics

停牌 07-30 19:56:09 EDT

11.13

+0.00

0.00%

最高11.13	最低11.13	成交量0.00
今开11.13	昨收11.13	日振幅0.00%
总市值9.94亿	流通市值7.29亿	总股本8,932万
成交额0.00	换手率0.00%	流通股本6,550万
市净率2.10	ROE-34.26%	每股收益-2.10
52周最高11.41	52周最低2.86	市盈率-5.30
股息0.00	股息收益率0.00	ROA-19.35%

北京优虎网络科技有限公司

{"stockData":{"symbol":"VERV","market":"US","secType":"STK","nameCN":"Verve Therapeutics","latestPrice":11.13,"timestamp":1753905600000,"preClose":11.13,"halted":3,"volume":0,"delay":0,"floatShares":65495092,"shares":89320995,"eps":-2.101349,"marketStatus":"停牌","change":0,"latestTime":"07-30 19:56:06 EDT","open":11.13,"high":11.13,"low":11.13,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.101349,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1753920000000},"marketStatusCode":4,"adr":0,"listingDate":1623902400000,"exchange":"NASDAQ","adjPreClose":11.13,"volumeRatio":0},"requestUrl":"/m/hq/s/VERV","defaultTab":"news","newsList":[{"id":"2544964319","title":"William Blair：下调Verve Therapeutics(VERV.US)评级，由优于大市调整至大市一致评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2544964319","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544964319?lang=zh_cn&edition=full","pubTime":"2025-06-17 23:05","pubTimestamp":1750172712,"startTime":"0","endTime":"0","summary":"William Blair：下调Verve Therapeutics(VERV.US)评级，由优于大市调整至大市一致评级。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/17230551130035.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["VERV","LENZ"],"gpt_icon":0},{"id":"1181800361","title":"异动解读 | Verve Therapeutics股价盘中暴涨74.32%，礼来130亿美元收购offer引爆","url":"https://stock-news.laohu8.com/highlight/detail?id=1181800361","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181800361?lang=zh_cn&edition=full","pubTime":"2025-06-17 22:10","pubTimestamp":1750169438,"startTime":"0","endTime":"0","summary":"周二，基因编辑公司Verve Therapeutics股价在盘中大涨74.32%，引发市场广泛关注。这一显著涨幅主要源于一则重大收购消息。据报道，全球制药巨头礼来公司 已宣布将以最高13亿美元的价格收购Verve Therapeutics。根据协议条款，礼来将以每股10.50美元的现金价格发起要约收购，总计约10亿美元。截至周一收盘，Verve的市值仅为5.59亿美元，礼来的收购报价几乎是其当前市值的两倍，溢价率高达113%。Verve Therapeutics专注于开发针对心血管疾病的基因编辑疗法。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["VERV"],"gpt_icon":1},{"id":"2544966004","title":"礼来公司是否即将收购Verve Therapeutics？Is Lilly about to swoop on Verve Therapeutics?","url":"https://stock-news.laohu8.com/highlight/detail?id=2544966004","media":"动脉网","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544966004?lang=zh_cn&edition=full","pubTime":"2025-06-17 18:25","pubTimestamp":1750155900,"startTime":"0","endTime":"0","summary":"The biotech grapevine is dripping with speculation that Eli Lilly is about to make a $1.3 billion takeover bid for Verve Therapeutics, upgrading a collaboration between the two companies that dates back to 2023.生物技术界的传闻盛传，礼来公司即将以 13 亿美元的价格收购 Verve Therapeutics，这将升级两家公司自 2023 年以来的合作关系。A report in the报告在Financial Times金融时报suggests that Lilly is in advanced talks to acquire Verve at a time when it is due to make an opt-in decision on a PCSK9 inhibitor candidate for cardiovascular diseases.表明礼来公司正在就收购韦尔夫进行深入谈判，而此时正值其即将就一款用于治疗心血管疾病的PCSK9抑制剂候选药物作出选择决定之际。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617182621952010ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617182621952010ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0882574139.USD","LU2237443549.SGD","LU2089984988.USD","LENZ","LU0058720904.USD","LU0122379950.USD","LU2602419157.SGD","SGXZ31699556.SGD","VERV","BK4516","LU1974910355.USD","LU0061475181.USD","LU2211815571.USD","LU2360106947.USD","LU0823416689.USD","LU0882574055.USD","SG9999015945.SGD","SG9999014880.SGD","LU2237438978.USD","LU2361045086.USD","LU0238689110.USD","LU1989771016.USD","IE00BK4W5L77.USD","LU1291159041.SGD","LU2471134952.CNY","LU1868837136.USD","LLY","LU2462157665.USD","LU2237443622.USD","LU1720051017.SGD","IE00BJJMRZ35.SGD","LU2417539215.USD","SGXZ57979304.SGD","LU0471298777.SGD","LU0820561818.USD","LU1267930730.SGD","BK4581","LU1023059063.AUD","IE00B2B36J28.USD","LU2265009873.SGD","GB00BDT5M118.USD","LU1280957306.USD","BK4533","LU1983299246.USD","LU1551013425.SGD","SG9999014906.USD","LU0256863811.USD","LU0266013472.USD","SG9999001176.USD","LU0320765992.SGD"],"gpt_icon":1},{"id":"1175302647","title":"盘前异动丨脑再生科技、Verve暴涨，能源股拉升，太阳能股普跌","url":"https://stock-news.laohu8.com/highlight/detail?id=1175302647","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175302647?lang=zh_cn&edition=full","pubTime":"2025-06-17 16:21","pubTimestamp":1750148513,"startTime":"0","endTime":"0","summary":"美股三大指数期货在盘前时段集体走低。","market":"us","thumbnail":"https://static.tigerbbs.com/1b1e94e562648cc7fdda832536b68158","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/1b1e94e562648cc7fdda832536b68158"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RBNE","RGC","VERV"],"gpt_icon":1},{"id":"1180253663","title":"基因编辑初创公司Verve盘前暴涨，礼来将以13亿美元收购该公司","url":"https://stock-news.laohu8.com/highlight/detail?id=1180253663","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180253663?lang=zh_cn&edition=full","pubTime":"2025-06-17 16:12","pubTimestamp":1750147949,"startTime":"0","endTime":"0","summary":"这家公司此前已与礼来建立合作关系。","market":"us","thumbnail":"https://static.tigerbbs.com/634dfb75e9846a8438b899e168e6df4c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/634dfb75e9846a8438b899e168e6df4c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERV"],"gpt_icon":0},{"id":"1174155580","title":"异动解读 | 基因编辑公司Verve Therapeutics盘前暴涨80.70%，或被礼来以13亿美元收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1174155580","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174155580?lang=zh_cn&edition=full","pubTime":"2025-06-17 16:10","pubTimestamp":1750147822,"startTime":"0","endTime":"0","summary":"基因编辑初创公司Verve Therapeutics周二盘前股价大涨80.70%，引发市场广泛关注。这一显著涨幅主要源于一则潜在收购消息。据英国《金融时报》报道，全球制药巨头礼来公司 正在就以高达13亿美元的价格收购Verve Therapeutics进行深入谈判。礼来的收购要约包括向Verve支付近10亿美元的预付款，以及在达到某些临床里程碑后再支付3亿美元。Verve Therapeutics目前正在开发一种降低高胆固醇水平的基因疗法，预计将与其他药物联合使用。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["VERV"],"gpt_icon":1},{"id":"2544589935","title":"盘后飙涨74.8%！基因编辑独角兽VERV获礼来13亿收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2544589935","media":"华尔街见闻","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544589935?lang=zh_cn&edition=full","pubTime":"2025-06-17 11:22","pubTimestamp":1750130543,"startTime":"0","endTime":"0","summary":"其中10亿美元为预付款，另外3亿美元将根据Verve达成特定临床里程碑支付。截至周一收盘，这家位于波士顿的生物技术公司市值仅为5.59亿美元，礼来的报价几乎是其当前市值的两倍。报道透露消息后，Verve Therapeutics盘后股价飙升超74%。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3749253","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3749253","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930730.SGD","LU2237438978.USD","LU2063271972.USD","LLY","LU2468319806.SGD","LU1127390331.HKD","LU0266013472.USD","LU0456855351.SGD","LU2491050071.SGD","LU2461242641.AUD","SG9999014898.SGD","LU1069344957.HKD","LU0109391861.USD","LU1804176565.USD","LU0354030438.USD","LU2264538146.SGD","LU2089984988.USD","IE00BK4W5M84.HKD","IE00BJJMRZ35.SGD","LU1061106388.HKD","LU1868836914.USD","BK4516","LU2746668461.USD","LU0689472784.USD","LU0882574055.USD","LU1868837136.USD","LU1917777945.USD","LU0823416689.USD","IE00B4R5TH58.HKD","BK4599","LU2491050154.USD","SGXZ81514606.USD","IE00BK4W5L77.USD","LU0203201768.USD","LU1720051017.SGD","LU2750360997.AUD","SG9999013999.USD","LU0889565916.HKD","LU0106261372.USD","LU0109394709.USD","VERV","LU2324357040.USD","LU1232071149.USD","LU2361044865.SGD","LU2237443978.SGD","LU0320765992.SGD","SG9999001176.SGD","LU0786609619.USD","BK4581"],"gpt_icon":1},{"id":"2544898017","title":"美股异动 | Verve Therapeutics(VERV.US)盘后大涨近75% 传接近获礼来以13亿美元收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2544898017","media":"智通财经","labels":["corporation","merge","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544898017?lang=zh_cn&edition=full","pubTime":"2025-06-17 09:24","pubTimestamp":1750123482,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据媒体周一报道，礼来公司 正在就收购基因编辑初创企业Verve Therapeutics 进行深入谈判，交易金额最高可达 13 亿美元，此举旨在强化其实验性药物的研发管线。消息公布，截至发稿，Verve Therapeutics股价盘后大涨74.8%。该制药公司的收购报价包括一次性支付近 10 亿美元用于收购Verve Therapeutics ，此外还根据这家基因药物公司的某些临床进展目标达成情况再支付 3 亿美元。Verve Therapeutics目前正在研发一种基因疗法，旨在降低高胆固醇水平，该疗法预计将与其他药物联合使用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1306035.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2750360641.GBP","LU0109391861.USD","LENZ","LU0943347566.SGD","LU2237443549.SGD","LU0417517546.SGD","LU0094547139.USD","LU1974910355.USD","LU0354030438.USD","LU2236285917.USD","LU2211815571.USD","LU2237443978.SGD","LU0061475181.USD","LU2462157665.USD","GB00BDT5M118.USD","LU0882574055.USD","LU1551013425.SGD","LU2112291526.USD","LU1064131342.USD","SG9999001176.USD","SG9999015952.SGD","IE00BJT1NW94.SGD","VERV","LU0471298777.SGD","BK4534","LU0203202063.USD","LU0882574139.USD","SG9999018865.SGD","LU1989771016.USD","BK4581","LU2417539215.USD","LU0096364046.USD","IE0002141913.USD","IE0009355771.USD","SG9999015945.SGD","LU0385154629.USD","SG9999015986.USD","LU0058720904.USD","LU2106854487.HKD","LU1127390331.HKD","LU1917777945.USD","BK4588","LU1057294990.SGD","LU0256863902.USD","LU0256863811.USD","LU1267930730.SGD","LU2264538146.SGD","SGXZ99366536.SGD","SG9999015978.USD","LLY"],"gpt_icon":0},{"id":"2539306265","title":"Verve Therapeutics, Inc.盘中异动 股价大跌6.13%报3.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539306265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539306265?lang=zh_cn&edition=full","pubTime":"2025-05-29 21:32","pubTimestamp":1748525574,"startTime":"0","endTime":"0","summary":"北京时间2025年05月29日21时32分，Verve Therapeutics, Inc.股票出现波动，股价快速下跌6.13%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家临床阶段的公司，正在开发一类新的心血管疾病基因药物，有可能将治疗从慢性疗法转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529213254a6f1f01a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529213254a6f1f01a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4007","BK4139","VERV"],"gpt_icon":0},{"id":"2537776923","title":"Verve Therapeutics, Inc.2025财年第一财季实现净利润-31.03百万美元，同比增加36.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537776923","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537776923?lang=zh_cn&edition=full","pubTime":"2025-05-23 00:00","pubTimestamp":1747929619,"startTime":"0","endTime":"0","summary":"5月23日，Verve Therapeutics, Inc.公布财报，公告显示公司2025财年第一财季净利润为-31.03百万美元，同比增加36.34%；其中营业收入为32.98百万美元，同比增加478.60%，每股基本收益为-0.35美元。从资产负债表来看，Verve Therapeutics, Inc.总负债1.41亿美元，其中短期债务10.52百万美元，资产负债比为4.36，流动比率为0.10。机构评级：截至2025年5月23日，当前有8家机构对Verve Therapeutics, Inc.目标价做出预测，其中目标均价为23.50美元，其中最低目标价为15.00美元，最高目标价为39.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000028a6e913e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000028a6e913e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERV","LENZ"],"gpt_icon":0},{"id":"2537293607","title":"Verve Therapeutics, Inc.盘中异动 早盘股价大跌5.21%报4.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537293607","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537293607?lang=zh_cn&edition=full","pubTime":"2025-05-21 21:42","pubTimestamp":1747834933,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日21时42分，Verve Therapeutics, Inc.股票出现波动，股价快速下挫5.21%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家临床阶段的公司，正在开发一类新的心血管疾病基因药物，有可能将治疗从慢性疗法转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052121421394fe0667&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052121421394fe0667&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","VERV","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2536633541","title":"Verve Therapeutics, Inc.盘中异动 股价大跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536633541","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536633541?lang=zh_cn&edition=full","pubTime":"2025-05-19 22:21","pubTimestamp":1747664485,"startTime":"0","endTime":"0","summary":"北京时间2025年05月19日22时21分，Verve Therapeutics, Inc.股票出现波动，股价急速下挫5.18%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家临床阶段的公司，正在开发一类新的心血管疾病基因药物，有可能将治疗从慢性疗法转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519222125aa2c92d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519222125aa2c92d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","VERV","LENZ","BK4139"],"gpt_icon":0},{"id":"2535314688","title":"Verve Therapeutics, Inc.盘中异动 快速拉升5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535314688","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535314688?lang=zh_cn&edition=full","pubTime":"2025-05-16 22:48","pubTimestamp":1747406913,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日22时48分，Verve Therapeutics, Inc.股票出现异动，股价急速拉升5.21%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Affimed N.V.、Inozyme Pharma, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Affimed N.V.、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为3758.71%、2232.19%、1180.06%，振幅较大的相关个股有Affimed N.V.、Vor Biopharma Inc.、Imunon, Inc.，振幅分别为466.98%、65.59%、42.74%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家临床阶段的公司，正在开发一类新的心血管疾病基因药物，有可能将治疗从慢性疗法转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516224834975be5a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516224834975be5a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BK4007","VERV","LENZ"],"gpt_icon":0},{"id":"2535682716","title":"Verve Therapeutics, Inc.盘中异动 早盘大幅下跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535682716","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535682716?lang=zh_cn&edition=full","pubTime":"2025-05-15 22:29","pubTimestamp":1747319376,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日22时29分，Verve Therapeutics, Inc.股票出现异动，股价急速跳水5.22%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家临床阶段的公司，正在开发一类新的心血管疾病基因药物，有可能将治疗从慢性疗法转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515222936975acbf6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515222936975acbf6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","BK4539","VERV"],"gpt_icon":0},{"id":"2535020474","title":"Verve Therapeutics, Inc.股价上涨12.02% 市值涨4993.19万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535020474","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535020474?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:32","pubTimestamp":1747229529,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时32分，Verve Therapeutics, Inc.股票出现波动，股价急速拉升12.02%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Septerna, Inc.、蓝鸟生物、Quoin Pharmaceuticals Ltd涨幅较大，Nucana Plc、Quoin Pharmaceuticals Ltd、Polyrizon Ltd.较为活跃，换手率分别为1971.30%、1181.45%、1073.83%，振幅较大的相关个股有Nucana Plc、Septerna, Inc.、Quoin Pharmaceuticals Ltd，振幅分别为23.40%、15.45%、14.94%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家临床阶段的公司，正在开发一类新的心血管疾病基因药物，有可能将治疗从慢性疗法转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213209a47e3e70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213209a47e3e70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","VERV","LENZ","BK4139"],"gpt_icon":0},{"id":"2535472650","title":"Verve Therapeutics(VERV.US)：2025年Q1财报实现营收3297.6万美元，前值为569.5万美元，预期值为938万美元；每股收益为-0.35美元，前值为-0.59美元，预期值为-0.65美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535472650","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535472650?lang=zh_cn&edition=full","pubTime":"2025-05-14 19:11","pubTimestamp":1747221078,"startTime":"0","endTime":"0","summary":"Verve Therapeutics(VERV.US)：2025年Q1财报实现营收3297.6万美元，前值为569.5万美元，预期值为938万美元；每股收益为-0.35美元，前值为-0.59美元，预期值为-0.65美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/14191150387942.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","VERV"],"gpt_icon":0},{"id":"2532122879","title":"Verve Therapeutics, Inc.盘中异动 快速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532122879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532122879?lang=zh_cn&edition=full","pubTime":"2025-05-03 03:42","pubTimestamp":1746214978,"startTime":"0","endTime":"0","summary":"北京时间2025年05月03日03时42分，Verve Therapeutics, Inc.股票出现波动，股价大幅下跌5.00%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.04%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家临床阶段的公司，正在开发一类新的心血管疾病基因药物，有可能将治疗从慢性疗法转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050303425894eaf07e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050303425894eaf07e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BK4007","VERV","LENZ"],"gpt_icon":0},{"id":"2532707150","title":"Verve Therapeutics, Inc.盘中异动 早盘股价大跌5.46%报5.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532707150","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532707150?lang=zh_cn&edition=full","pubTime":"2025-05-01 21:34","pubTimestamp":1746106445,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日21时34分，Verve Therapeutics, Inc.股票出现异动，股价快速下跌5.46%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.51%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家临床阶段的公司，正在开发一类新的心血管疾病基因药物，有可能将治疗从慢性疗法转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213405974c972f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213405974c972f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","VERV","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2532023067","title":"Verve Therapeutics, Inc.盘中异动 下午盘股价大涨5.13%报5.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532023067","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532023067?lang=zh_cn&edition=full","pubTime":"2025-05-01 03:24","pubTimestamp":1746041052,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日03时24分，Verve Therapeutics, Inc.股票出现异动，股价快速上涨5.13%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.46%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家临床阶段的公司，正在开发一类新的心血管疾病基因药物，有可能将治疗从慢性疗法转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501032412aa2c801f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501032412aa2c801f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VERV","LENZ","BK4007","BK4539"],"gpt_icon":0},{"id":"2531763880","title":"Verve Therapeutics, Inc.盘中异动 临近午盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531763880","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531763880?lang=zh_cn&edition=full","pubTime":"2025-04-29 23:51","pubTimestamp":1745941896,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日23时51分，Verve Therapeutics, Inc.股票出现波动，股价大幅下跌5.06%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.61%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家临床阶段的公司，正在开发一类新的心血管疾病基因药物，有可能将治疗从慢性疗法转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429235136a46c6196&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429235136a46c6196&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","VERV","BK4007","BK4139","BK4539"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vervetx.com","stockEarnings":[{"period":"1week","weight":0.0045},{"period":"1month","weight":-0.015},{"period":"3month","weight":0.963},{"period":"6month","weight":0.502},{"period":"1year","weight":0.5632},{"period":"ytd","weight":0.9734}],"compareEarnings":[{"period":"1week","weight":0.0102},{"period":"1month","weight":0.0331},{"period":"3month","weight":0.1456},{"period":"6month","weight":0.0499},{"period":"1year","weight":0.1661},{"period":"ytd","weight":0.0839}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Verve Therapeutics, Inc.于2018年3月9日成立为特拉华州公司。该公司是一家基因药物公司，开创了一种治疗心血管疾病或CVD的新方法，将治疗从慢性管理转变为单程基因编辑药物。该公司认为，单疗程治疗可以为患有动脉粥样硬化性心血管疾病或ASCVD或有患动脉粥样硬化性心血管疾病风险的患者提供终生持续的显著健康益处。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.020713},{"month":2,"riseRate":0.5,"avgChangeRate":0.093911},{"month":3,"riseRate":0,"avgChangeRate":-0.26032},{"month":4,"riseRate":0.5,"avgChangeRate":-0.137053},{"month":5,"riseRate":0.25,"avgChangeRate":-0.090943},{"month":6,"riseRate":0.75,"avgChangeRate":0.420756},{"month":7,"riseRate":0.6,"avgChangeRate":0.223194},{"month":8,"riseRate":0.5,"avgChangeRate":0.08013},{"month":9,"riseRate":0.25,"avgChangeRate":-0.170008},{"month":10,"riseRate":0.5,"avgChangeRate":0.044106},{"month":11,"riseRate":0,"avgChangeRate":-0.183311},{"month":12,"riseRate":0.75,"avgChangeRate":0.039001}],"exchange":"NASDAQ","name":"Verve Therapeutics","nameEN":"Verve Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Verve Therapeutics(VERV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Verve Therapeutics(VERV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Verve Therapeutics,VERV,Verve Therapeutics股票,Verve Therapeutics股票老虎,Verve Therapeutics股票老虎国际,Verve Therapeutics行情,Verve Therapeutics股票行情,Verve Therapeutics股价,Verve Therapeutics股市,Verve Therapeutics股票价格,Verve Therapeutics股票交易,Verve Therapeutics股票购买,Verve Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Verve Therapeutics(VERV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Verve Therapeutics(VERV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}